| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
24,503 |
20,827 |
$1.19M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,684 |
15,516 |
$619K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,037 |
6,189 |
$316K |
| 99348 |
|
4,919 |
2,792 |
$262K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,545 |
3,048 |
$190K |
| 99384 |
|
1,744 |
1,480 |
$131K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
937 |
770 |
$74K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,980 |
4,056 |
$74K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,879 |
2,918 |
$70K |
| 99349 |
|
839 |
551 |
$67K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,326 |
1,036 |
$42K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
448 |
395 |
$33K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
965 |
859 |
$32K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,441 |
3,042 |
$29K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
273 |
263 |
$28K |
| 99347 |
|
760 |
700 |
$26K |
| 96136 |
|
769 |
551 |
$23K |
| 99173 |
|
2,794 |
2,286 |
$20K |
| 36415 |
Collection of venous blood by venipuncture |
10,000 |
8,475 |
$19K |
| 86580 |
|
2,281 |
1,818 |
$14K |
| 80305 |
|
1,250 |
1,107 |
$8K |
| 81002 |
|
4,087 |
3,569 |
$8K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
63 |
41 |
$8K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
269 |
207 |
$7K |
| 87428 |
|
147 |
138 |
$7K |
| 92552 |
|
473 |
428 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
66 |
60 |
$5K |
| 96103 |
|
246 |
163 |
$3K |
| 95923 |
|
39 |
39 |
$3K |
| 99383 |
|
32 |
31 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
28 |
25 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,979 |
1,632 |
$2K |
| 81025 |
|
370 |
309 |
$2K |
| 93922 |
|
24 |
24 |
$2K |
| 96127 |
|
386 |
313 |
$1K |
| 96160 |
|
77 |
59 |
$1K |
| 99215 |
Prolong outpt/office vis |
15 |
15 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
156 |
148 |
$1K |
| 81003 |
|
1,004 |
795 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
15 |
15 |
$1K |
| 95943 |
|
28 |
28 |
$794.91 |
| 90686 |
|
147 |
129 |
$785.28 |
| 96146 |
|
653 |
572 |
$698.68 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
400 |
340 |
$619.63 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
28 |
26 |
$581.26 |
| 1159F |
|
5,816 |
4,853 |
$500.00 |
| 95117 |
|
45 |
26 |
$493.60 |
| K1034 |
Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count |
719 |
482 |
$438.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
19 |
17 |
$392.23 |
| 92587 |
|
17 |
14 |
$316.97 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
77 |
74 |
$282.64 |
| 90674 |
|
12 |
12 |
$158.82 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
66 |
56 |
$103.49 |
| 99051 |
|
47 |
34 |
$101.43 |
| 99406 |
|
12 |
12 |
$89.61 |
| 3008F |
|
6,391 |
5,425 |
$80.00 |
| 3079F |
|
162 |
151 |
$30.00 |
| 90461 |
|
117 |
98 |
$22.87 |
| 3074F |
|
246 |
230 |
$20.00 |
| 3077F |
|
26 |
26 |
$20.00 |
| 3080F |
|
14 |
13 |
$10.00 |
| 3078F |
|
103 |
100 |
$10.00 |
| 99070 |
|
111 |
102 |
$4.80 |
| 99000 |
|
11,355 |
9,572 |
$4.32 |
| 1036F |
|
3,485 |
2,895 |
$0.00 |
| 3075F |
|
13 |
13 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
68 |
61 |
$0.00 |
| 1034F |
|
48 |
39 |
$0.00 |
| 4000F |
|
15 |
14 |
$0.00 |
| 1126F |
|
19 |
19 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
859 |
752 |
$0.00 |
| 3725F |
|
120 |
95 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
371 |
332 |
$0.00 |
| 90715 |
|
29 |
23 |
$0.00 |
| 90734 |
|
39 |
34 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
22 |
22 |
$0.00 |
| 90649 |
|
24 |
20 |
$0.00 |
| 4035F |
|
15 |
12 |
$0.00 |
| 4004F |
|
12 |
12 |
$0.00 |
| 1160F |
|
34 |
32 |
$0.00 |